CAI Sale Disclosure
Spetzler David Baxley · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$2.95M
Spetzler David Baxley President
CAI
Transaction date
Sep 4, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed same day
CAI daily price context
Close on/before transaction
$25.07
Sep 4, 2026
Close before public filing
$25.32
Sep 3, 2026
Return since public filing
+19.27%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 119,212 shares @ $24.76
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002071953-26-000007
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$17.88M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Caris Life Sciences, Inc. CAI | Exercise | Sep 4, 2026 | $0 |
| Caris Life Sciences, Inc. CAI Current | Sale | Sep 4, 2026 | $2.95M |
| Caris Life Sciences, Inc. CAI | Exercise | Sep 4, 2026 | $610K |
| Caris Life Sciences, Inc. CAI | Sale | Sep 3, 2026 | $2.15M |
| Caris Life Sciences, Inc. CAI | Exercise | Sep 3, 2026 | $0 |
| Caris Life Sciences, Inc. CAI | Sale | Sep 3, 2026 | $9.73M |
| Caris Life Sciences, Inc. CAI | Exercise | Sep 3, 2026 | $2.44M |